For rbsurv analysis, there were 7 AR DEGs related to prognosis of BLCA patients, containing inhibin B (INHBB), fatty acid synthase(FASN), special AT-rich sequence binding protein 1 (SATB1), calreticulin (CALR), hepatocyte growth factor (HGF), caveolin 1 (CAV1), and chondroitin sulfate proteoglycan 4 (CSPG4) (Table 3). The gene discussed is CAV1; the disease is bladder transitional cell carcinoma.